A next-generation cancer vaccine has shown stunning results in mice, preventing up to 88% of aggressive and ...

INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, today announces that David Moss, Chief Executive Officer will participate in a Dermatologic Rare Disease Panel at ...

Experts say diet can make a real difference- but it's not as simple as consuming one magic food or taking a supplement.

This review examines how Western dietary patterns, high in ultra-processed foods, salt, and unhealthy fats, disrupt gut ...

Tuberculosis (TB) remains a major global health challenge, affecting more than 10 million people annually worldwide, with ...

A new research paper was published in Volume 16 of Oncotarget on October 6, 2025, titled "ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL ...

Broad rim lesions have been identified as a new biomarker for rapid multiple sclerosis progression, offering key insights ...

Understanding how interactions between the central nervous system and the immune system contribute to problems of aging, ...

A new research paper was published in Volume 16 of Oncotarget on October 6, 2025, titled “ACTM-838, a novel systemically ...

Although experts may disagree on how to classify neurogenic rosacea pain, they advise dermatologists to get more comfortable with appropriate off-label treatments.

Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced the publication of ...

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB:BVAXF) ("BioVaxys" or "Company") is pleased to announce that James ...